Dr. Jeffrey Chamberlain's lab focuses on developing advanced gene therapies for Duchenne muscular dystrophy (DMD), a severe genetic disorder. The lab aims to improve the delivery and function of dystrophin proteins, utilizing innovative vector technologies. By designing new methods for gene replacement and editing, the research seeks to enhance the effectiveness and safety of treatments for DMD and related neuromuscular disorders.

Dr. Payal Patel's lab at the University of Washington investigates the links between HIV and cognitive health in young adults. The research focuses on understanding how myelin, a key component of brain white matter, may be affected in individuals living with HIV, even those who are virally suppressed. This work aims to identify risks for cognitive impairment and explore potential interventions to improve brain health.